English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94201/94201 (100%)
造訪人次 : 81563955      線上人數 : 3927
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/103453


    題名: Detection of lysyl oxidase-like 2 (LOXL2), a biomarker of metastasis from breast cancers using human blood samples
    作者: 劉炯權;Janyasupab, Metini;Lee, Ying-Hui;Zhang, Yuan;Liu, Chen W;Cai, Jieyi;Popa, Adriana;Samia, Anna C;Wang, Kuan W;Xu, Jiaqiang;Hu, Chi-Chang;Wendt, Michael K;Schiemann, Barbara J;Thompson, Cheryl L;Yen, Yun;Schiemann, William P;Liu, Chung C
    貢獻者: 工學院材料科學與工程研究所
    日期: 2015-08-01
    上傳時間: 2026-04-23 11:30:47 (UTC+8)
    出版者: Bentham Science Publishers B.V.;United Arab Emirates: Bentham Science Publishers Ltd
    摘要: 摘要: Metastasis accounts for 90% of the mortality associated with breast cancer. Upregulated expression of members of the lysyl oxidase (LOX) family of secreted copper amine oxidases catalyzes the crosslinking of collagens and elastin in the extracellular matrix. LOXs are linked to the development and metastatic progression of breast cancers. Accordingly, aberrant expression of LOX-like 2 (LOXL2) is observed in poorly differentiated, high-grade tumors and is predictive of diseases recurrence, and for decreased overall patient survival. Therefore, LOXL2 expression may serve as a biomarker for breast cancer. Mechanistically, hydrogen peroxide is produced as a byproduct of LOXL2 when using an appropriate substrate, lysine. We exploited this chemistry to generate a revolutionary gold-based electrochemical biosensor capable of accurately detecting nanomolar quantities of LOXL2 in mouse blood, and in human blood samples. Two different sources of the blood samples obtained from breast cancer patients were used in this study indicating the applicability of detecting LOXL2 in breast cancers patients. Limited numbers of urine specimens from breast cancer patients were also tested. Collectively, all of these tests show the promise and potential of this biosensor for detecting LOXL2 as a surrogate biomarker of breast cancer. This work is described in patent number WO2014052962 (2014).
    其他題名: RPBM
    出版者: United Arab Emirates: Bentham Science Publishers Ltd
    出版日期: 2015-01-01
    出處: Recent patents on biomarkers, 2015-01, Vol.5 (2), p.93-100
    識別號: ISSN: 2210-3090
    識別號: ISSN: 2210-3104
    識別號: EISSN: 2210-3104
    識別號: DOI: 10.2174/2210309005666150804195033
    識別號: PMID: 28670509
    顯示於類別:[材料科學與工程研究所 ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML25檢視/開啟


    在NCUIR中所有的資料項目都受到原著作權保護.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明